|
个人信息Personal Information
副主任医师
硕士生导师
性别：男
出生日期：1988-04-20
学位：博士
所在单位：临床医学院
学科：生物医学工程. 生物工程与技术. 药物化学
办公地点：大连理工大学附属肿瘤医院（辽宁省肿瘤医院）沈抚院区6号楼8楼
联系方式：
电子邮箱：
移动版主页
- [1]Kang, Yue.李盛龙.管愉静.Innovative hydrogel solutions for articular cartilage regeneration: a comprehensive review[J],INTERNATIONAL JOURNAL OF SURGERY,2024,110(12):7984-8001
- [2]Liu, Qiang.李盛龙.管愉静.Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the "all-around warrior" in immunotherapy (vol 23, 183, 2024)[J],MOLECULAR CANCER,2024,23(1)
- [3]管愉静.Zhang, Wei,Mao, Yuling,李盛龙.Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment[J],MOLECULAR CANCER,2024,23(1)
- [4]Qu, Zhigang.Yue, Jiaji,Song, Ning,李盛龙.Innovations in three-dimensional-printed individualized bone prosthesis materials: revolutionizing orthopedic surgery: a review[J],INTERNATIONAL JOURNAL OF SURGERY,2024,110(10):6748-6762
- [5]刘强.李盛龙.管愉静.Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy[J],MOLECULAR CANCER,2024,23(1)
- [6]Zhao, Yuwei.李盛龙.Critique of CSPH impact on HCC surgical outcomes[J],HEPATOLOGY INTERNATIONAL,2025
- [7]Yang, Chao.李盛龙,Wang, Liming.Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics[J],MOLECULAR CANCER,2025,24(1)
- [8]Su, Yang.Qi, Xiaoqin,Liu, Yuan,Yang, Baiyan,Li, Yun,Li, Dongnan,李盛龙,Wang, Chunling,Yu, Liang,Xu, Xiaodi,Yang, Guang,Chen, Bi,Chen, Xi,Chen, Qiuni,Lv, Kebing,Zhang, Zhe,Liu, Hong.Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies[J],CANCER LETTERS,2025,633
- [9]Li, Zhipeng.Yang, Fan,Lu, Siyuan,Wu, Xinhao,李盛龙,Wang, Minghao.Neuroimmunology-driven CAR T-cell therapeutics for gliomas: translational challenges and clinical trial paradigm innovation[J],CANCER LETTERS,2025,631
- [10]Zhao, Xi.Ran, Jialing,李盛龙,Chen, Jinxin.Advances and obstacles of T cell-based immunotherapy in gynecological malignancies[J],MOLECULAR CANCER,2025,24(1)